Logo
x

Search

Subscribe Now

Medicines

Alvotech and Fuji Pharma Extends Agreement for the Commercialization of Four Biosimilars in Japan

Alvotech and Fuji Pharma Extends Agreement for the Commercialization of Four Biosimilars in Japan

  • December 14, 2020
Sangamo Signs a Worldwide License Agreement with Novartis to Develop Genomic Therapies for Three Neurodevelopmental Targets

Sangamo Signs a Worldwide License Agreement with Novartis to Develop Genomic Therapies for Three Neurodevelopmental Targets

  • July 30, 2020
LaNova Medicines Reports the Commencement of P-I Study Evaluating LM-299 for Solid Tumors and Completes Series C1 Financing Round

    LaNova Medicines Reports the Commencement of P-I Study Evaluating LM-299 for Solid Tumors and Completes Series C1 Financing Round

    • October 18, 2024
    Know Your Investor: Samsara Biocapital (October’24 Edition)

      Know Your Investor: Samsara Biocapital (October’24 Edition)

      • October 17, 2024
      Disease of the Month – Psoriatic arthritis

        Disease of the Month – Psoriatic arthritis

        • October 16, 2024
        Generate:Biomedicines Partners with Novartis for the Discovery of Protein Therapeutics in Various Indications

          Generate:Biomedicines Partners with Novartis for the Discovery of Protein Therapeutics in Various Indications

          • September 24, 2024
          Disease of the Month – Systemic Lupus Erythematosus

            Disease of the Month – Systemic Lupus Erythematosus

            • September 18, 2024
            FDA Overview and Its Role in Transforming the Pharmaceutical Landscape

              FDA Overview and Its Role in Transforming the Pharmaceutical Landscape

              • August 30, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.